Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 202377
Company: TORRENT
Company: TORRENT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
AMLODIPINE BESYLATE AND VALSARTAN | AMLODIPINE BESYLATE; VALSARTAN | EQ 5MG BASE;160MG | TABLET;ORAL | Discontinued | None | No | No |
AMLODIPINE BESYLATE AND VALSARTAN | AMLODIPINE BESYLATE; VALSARTAN | EQ 5MG BASE;320MG | TABLET;ORAL | Discontinued | None | No | No |
AMLODIPINE BESYLATE AND VALSARTAN | AMLODIPINE BESYLATE; VALSARTAN | EQ 10MG BASE;160MG | TABLET;ORAL | Discontinued | None | No | No |
AMLODIPINE BESYLATE AND VALSARTAN | AMLODIPINE BESYLATE; VALSARTAN | EQ 10MG BASE;320MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/30/2015 | ORIG-1 | Approval |
Label is not available on this site. |